Developer docs
API playgroundTry for free, no card

Search company profiles

Regulis

Full company profile

uuid0027w88

Namestring
Regulis
Legal namestring
Cencora Global Consulting Services UK Limited
Websiteurl
regulis.com
Company typeenum
Private
Founded yearint
2001
Descriptiontext

Regulis operates a UK-based pharmaceutical, biopharmaceutical, medical device, and cosmetics consulting practice that trades as PharmaLex and is legally constituted as Cencora Global Consulting Services UK Limited, a subsidiary of Cencora (formerly AmerisourceBergen). The firm, headquartered in Tring with additional offices in Redruth and Colchester, provides specialized regulatory affairs, pharmacovigilance, clinical development, market access, CMC, statistics, and quality management/compliance services to pharmaceutical, biotech, and medical device clients across the UK, Ireland, and Nordics. The service portfolio spans the full product lifecycle, from development strategy and clinical trial applications through regulatory submissions, post-approval maintenance, promotional materials compliance, and ongoing patient safety monitoring, supported by a senior team with deep regulatory agency experience and active involvement in industry bodies such as PIPA and the TMF Reference Model Steering Committee.

The practice is organized around five core departments — Research and Development, Statistics and Data Science, Market Access, Patient Safety (Pharmacovigilance), and Regulatory Affairs and CMC — with an additional Quality Management and Compliance function and a dedicated training platform at learn.pharmalex.com. Business is generated primarily through direct enterprise engagement, with senior directors and business development managers owning defined regional territories, supplemented by an active content marketing program (white papers, case studies, webinars, journal articles) and participation in industry conferences.

Revenue mechanics are not publicly disclosed; consulting engagements are scoped on a project basis and pricing is not published. The entity holds ISO 9001 quality management certification and operates without disclosed AI/ML capabilities, relying on senior human expertise rather than automated platforms. As a privately held subsidiary of a Fortune 500 parent, the unit benefits from Cencora's capital and back-office scale but does not disclose standalone revenue, headcount, or financial metrics.

Short descriptiontext

Regulis is a UK-based pharmaceutical, biotech, and medical device consulting firm, trading as PharmaLex under Cencora, providing regulatory affairs, pharmacovigilance, clinical development, and market access services to enterprise clients across the UK, Ireland, and Nordics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTring, United Kingdom
HQ citystring
Tring
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical consulting, regulatory affairs services, pharmacovigilance consulting, clinical development services, market access consulting
Industry3 codes
PRIMARYHLAGAAAH
Pharmacovigilance, Risk Management & Medical Affairs CROs
SECONDARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYBPAEAPAB
Regulatory Compliance Management (RegTech)
NAICS code1 code
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Management Services8741
Product category
Pharmaceutical Regulatory and Scientific Consulting
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Regulis provides specialised consulting services to the pharmaceutical, biopharmaceutical, medical device, and cosmetics industries through its PharmaLex service brand. Its offerings cover the full product lifecycle — including regulatory affairs and CMC, pharmacovigilance (patient safety), clinical development, biostatistics and data science, market access, and quality management and compliance — delivered from UK offices with global reach via its parent Cencora.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

PharmaLex is a service brand within Cencora (formerly AmerisourceBergen) offering specialized consulting services for the pharmaceutical, biotech, and medical device industries. The portfolio encompasses departments including Research and Development, Statistics and Data Science, Market Access, Patient Safety (Pharmacovigilance), and Regulatory Affairs and CMC. Services range from clinical development and toxicological assessments to regulatory writing, TMF services, and compliance training delivered through learn.pharmalex.com.

Product and service6 records
1Strategic and Scientific Consultancy
CategoryPharmaceutical Consulting
Description

Cross-functional strategic and scientific advisory engagements for pharmaceutical, biotech, and medical device clients spanning regulatory, clinical, and scientific decision support.

2Innovations to Market
CategoryPharmaceutical Consulting
Description

End-to-end consulting offering helping pharmaceutical and biotech innovators move new products from development into regulated markets, including development strategy, clinical trial applications, CMC, and regulatory submissions.

3Optimal Patient Access
CategoryMarket Access Consulting
Description

Market access consultancy covering HEOR, market access strategy, pricing and reimbursement, and patient access planning for pharmaceutical and biotech products.

4Business and Portfolio Mergers & Acquisitions
CategoryPharmaceutical Consulting
Description

Consulting service supporting mergers, acquisitions, and portfolio transactions in the pharmaceutical and biotech industries, including due diligence and integration regulatory support.

5Local Affiliate Services
CategoryPharmacovigilance / Regulatory Affairs
Description

Local affiliate pharmacovigilance and regulatory support services that allow global pharmaceutical companies to maintain compliant local operations across multiple jurisdictions.

6PharmaLex Training (learn.pharmalex.com)
CategoryProfessional Training
Description

Dedicated learning platform (learn.pharmalex.com) offering specialised training courses for pharmaceutical industry professionals across regulatory, pharmacovigilance, clinical, and market access topics.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Clinipace Worldwide is a mid-size CRO offering clinical research, regulatory affairs, and biostatistics services. As a smaller specialized player, it competes with Regulis in niche pharma consulting engagements.

TypeDirect peer
Description

Worldwide Clinical Trials is a mid-size CRO offering clinical development, regulatory affairs, and pharmacovigilance services. It directly competes with Regulis in specialized pharma consulting engagements.

TypeDirect peer
Description

Syneos Health is a fully integrated biopharmaceutical solutions organization offering clinical development, regulatory affairs, and pharmacovigilance consulting. It competes directly with Regulis in regulatory and clinical consulting services.

TypeBroad incumbent
Description

IQVIA is the world's largest CRO with extensive regulatory affairs, pharmacovigilance, and market access capabilities. As a broader incumbent, it competes with Regulis on enterprise-level regulatory engagements while offering a much wider portfolio including data, technology, and commercial services.

TypeDirect peer
Description

Medpace is a full-service CRO with regulatory affairs, clinical operations, and pharmacovigilance capabilities. It competes with Regulis in providing regulatory and clinical consulting to pharma and biotech companies.

TypeDirect peer
Description

Charles River Laboratories provides CRO services including regulatory affairs support, pharmacovigilance, and CMC consulting. It competes with Regulis in regulatory and safety services for pharma and biotech clients.

TypeDirect peer
Description

Parexel is a global CRO offering regulatory affairs, clinical development, pharmacovigilance, and market access consulting. It directly competes with Regulis/PharmaLex in pharma regulatory consulting and has comparable service breadth across the product lifecycle.

TypeDirect peer
Description

ICON plc is a global CRO providing clinical development, regulatory affairs, and pharmacovigilance services. It competes directly with Regulis in regulatory consulting and clinical trial services for pharma, biotech, and medical device clients.

TypeDirect peer
Description

ProPharma Group provides regulatory compliance, pharmacovigilance, and quality assurance consulting to pharma and medical device companies. It is one of the most direct specialized competitors to Regulis's regulatory and pharmacovigilance consulting offering.

TypeBroad incumbent
Description

PPD, now part of Thermo Fisher Scientific, is a global CRO with extensive regulatory affairs, clinical development, and pharmacovigilance capabilities. As a broad incumbent, it competes with Regulis on enterprise regulatory engagements.

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Regulis

Pharmaceutical Regulatory and Scientific Consultingregulis.com

Regulis is a UK-based pharmaceutical, biotech, and medical device consulting firm, trading as PharmaLex under Cencora, providing regulatory affairs, pharmacovigilance, clinical development, and market access services to enterprise clients across the UK, Ireland, and Nordics.

What Regulis does

Regulis operates a UK-based pharmaceutical, biopharmaceutical, medical device, and cosmetics consulting practice that trades as PharmaLex and is legally constituted as Cencora Global Consulting Services UK Limited, a subsidiary of Cencora (formerly AmerisourceBergen). The firm, headquartered in Tring with additional offices in Redruth and Colchester, provides specialized regulatory affairs, pharmacovigilance, clinical development, market access, CMC, statistics, and quality management/compliance services to pharmaceutical, biotech, and medical device clients across the UK, Ireland, and Nordics. The service portfolio spans the full product lifecycle, from development strategy and clinical trial applications through regulatory submissions, post-approval maintenance, promotional materials compliance, and ongoing patient safety monitoring, supported by a senior team with deep regulatory agency experience and active involvement in industry bodies such as PIPA and the TMF Reference Model Steering Committee.

The practice is organized around five core departments — Research and Development, Statistics and Data Science, Market Access, Patient Safety (Pharmacovigilance), and Regulatory Affairs and CMC — with an additional Quality Management and Compliance function and a dedicated training platform at learn.pharmalex.com. Business is generated primarily through direct enterprise engagement, with senior directors and business development managers owning defined regional territories, supplemented by an active content marketing program (white papers, case studies, webinars, journal articles) and participation in industry conferences.

Revenue mechanics are not publicly disclosed; consulting engagements are scoped on a project basis and pricing is not published. The entity holds ISO 9001 quality management certification and operates without disclosed AI/ML capabilities, relying on senior human expertise rather than automated platforms. As a privately held subsidiary of a Fortune 500 parent, the unit benefits from Cencora's capital and back-office scale but does not disclose standalone revenue, headcount, or financial metrics.

Regulis firmographics

Firmographics
Name
Regulis
Legal name
Cencora Global Consulting Services UK Limited
Website
https://regulis.com
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
11–50 employees
Short description
Regulis is a UK-based pharmaceutical, biotech, and medical device consulting firm, trading as PharmaLex under Cencora, providing regulatory affairs, pharmacovigilance, clinical development, and market access services to enterprise clients across the UK, Ireland, and Nordics.
Ownership category
akta.pro rank

Regulis industry classification

Industry
Product category
Pharmaceutical Regulatory and Scientific Consulting
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Management Services (8741)
akta.pro industry
PRIMARYHLAGAAAH
Pharmacovigilance, Risk Management & Medical Affairs CROs
SECONDARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYBPAEAPAB
Regulatory Compliance Management (RegTech)

Keywords

  • Pharmaceutical consulting
  • Regulatory affairs services
  • Pharmacovigilance consulting
  • Clinical development services
  • Market access consulting

Where Regulis is headquartered

Location

Headquarters

HQ city
Tring
HQ country
United Kingdom
HQ region
Europe

Offices3 records

Markets served

Regulis business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Distribution channels1 record

Marketing channels8 records

Regulis product offering

Product offering

Core offering

Regulis provides specialised consulting services to the pharmaceutical, biopharmaceutical, medical device, and cosmetics industries through its PharmaLex service brand. Its offerings cover the full product lifecycle — including regulatory affairs and CMC, pharmacovigilance (patient safety), clinical development, biostatistics and data science, market access, and quality management and compliance — delivered from UK offices with global reach via its parent Cencora.

Product overview

PharmaLex is a service brand within Cencora (formerly AmerisourceBergen) offering specialized consulting services for the pharmaceutical, biotech, and medical device industries. The portfolio encompasses departments including Research and Development, Statistics and Data Science, Market Access, Patient Safety (Pharmacovigilance), and Regulatory Affairs and CMC. Services range from clinical development and toxicological assessments to regulatory writing, TMF services, and compliance training delivered through learn.pharmalex.com.

Differentiator

Problem solved

Functional benefit

Products and services

  • Strategic and Scientific Consultancy Cross-functional strategic and scientific advisory engagements for pharmaceutical, biotech, and medical device clients spanning regulatory, clinical, and scientific decision support.
  • Innovations to Market End-to-end consulting offering helping pharmaceutical and biotech innovators move new products from development into regulated markets, including development strategy, clinical trial applications, CMC, and regulatory submissions.
  • Optimal Patient Access Market access consultancy covering HEOR, market access strategy, pricing and reimbursement, and patient access planning for pharmaceutical and biotech products.
  • Business and Portfolio Mergers & Acquisitions Consulting service supporting mergers, acquisitions, and portfolio transactions in the pharmaceutical and biotech industries, including due diligence and integration regulatory support.
  • Local Affiliate Services Local affiliate pharmacovigilance and regulatory support services that allow global pharmaceutical companies to maintain compliant local operations across multiple jurisdictions.
  • PharmaLex Training (learn.pharmalex.com) Dedicated learning platform (learn.pharmalex.com) offering specialised training courses for pharmaceutical industry professionals across regulatory, pharmacovigilance, clinical, and market access topics.

Companies that use Regulis

Customer profile

Segments3 records

Ideal customer profiles3 records

Regulis technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Regulis partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights5 records

Regulis competitors and assessment

Company assessment

Emerging players

  • Clinipace Worldwide: Clinipace Worldwide is a mid-size CRO offering clinical research, regulatory affairs, and biostatistics services. As a smaller specialized player, it competes with Regulis in niche pharma consulting engagements.

Direct peers

  • Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-size CRO offering clinical development, regulatory affairs, and pharmacovigilance services. It directly competes with Regulis in specialized pharma consulting engagements.
  • Syneos Health: Syneos Health is a fully integrated biopharmaceutical solutions organization offering clinical development, regulatory affairs, and pharmacovigilance consulting. It competes directly with Regulis in regulatory and clinical consulting services.
  • Medpace: Medpace is a full-service CRO with regulatory affairs, clinical operations, and pharmacovigilance capabilities. It competes with Regulis in providing regulatory and clinical consulting to pharma and biotech companies.
  • Charles River Laboratories: Charles River Laboratories provides CRO services including regulatory affairs support, pharmacovigilance, and CMC consulting. It competes with Regulis in regulatory and safety services for pharma and biotech clients.
  • Parexel International: Parexel is a global CRO offering regulatory affairs, clinical development, pharmacovigilance, and market access consulting. It directly competes with Regulis/PharmaLex in pharma regulatory consulting and has comparable service breadth across the product lifecycle.
  • ICON plc: ICON plc is a global CRO providing clinical development, regulatory affairs, and pharmacovigilance services. It competes directly with Regulis in regulatory consulting and clinical trial services for pharma, biotech, and medical device clients.
  • ProPharma Group: ProPharma Group provides regulatory compliance, pharmacovigilance, and quality assurance consulting to pharma and medical device companies. It is one of the most direct specialized competitors to Regulis's regulatory and pharmacovigilance consulting offering.

Broad incumbents

  • IQVIA: IQVIA is the world's largest CRO with extensive regulatory affairs, pharmacovigilance, and market access capabilities. As a broader incumbent, it competes with Regulis on enterprise-level regulatory engagements while offering a much wider portfolio including data, technology, and commercial services.
  • PPD (Thermo Fisher Scientific): PPD, now part of Thermo Fisher Scientific, is a global CRO with extensive regulatory affairs, clinical development, and pharmacovigilance capabilities. As a broad incumbent, it competes with Regulis on enterprise regulatory engagements.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Regulis social profiles

Digital presence

Regulis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Regulis leadership team

Management profile

Number of profiles

Profiles15 records

Regulis funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Regulis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Regulis

What does Regulis do?

Regulis provides specialised consulting services to the pharmaceutical, biopharmaceutical, medical device, and cosmetics industries through its PharmaLex service brand. Its offerings cover the full product lifecycle — including regulatory affairs and CMC, pharmacovigilance (patient safety), clinical development, biostatistics and data science, market access, and quality management and compliance — delivered from UK offices with global reach via its parent Cencora.

Is Regulis a public or private company?

Regulis is a private company. It is classified as corporate owned and is currently operating.

When was Regulis founded?

Regulis was founded in 2001. It employs 11 to 50 people.

Where is Regulis based?

Regulis is headquartered in Tring, United Kingdom, in the Europe region.

Who are Regulis's main competitors?

Clinipace Worldwide is listed as an emerging player. Direct peers are Worldwide Clinical Trials, Syneos Health, Medpace, Charles River Laboratories, Parexel International, ICON plc and ProPharma Group. Broad incumbents are IQVIA and PPD (Thermo Fisher Scientific).

Does Regulis have an API?

No public API is recorded for Regulis.

What industry is Regulis in?

Regulis's product category is Pharmaceutical Regulatory and Scientific Consulting. Its primary akta.pro industry code is HLAGAAAH, Pharmacovigilance, Risk Management & Medical Affairs CROs, with a secondary code of HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 54171 and its SIC code is 8741.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals